To determine the extent of tumor lysis due to T cells, we performed a cytotoxicity assay with ex vivo-isolated CD8+ T cells, which were either transfected with a gp100-specific TCR enabling antigen-specific T cell cytotoxicity (T cellsgp100) or left unequipped serving as mock controls (T cellsmock). The gene discussed is PMEL; the disease is neoplasm.